Related Experiment Video
Updated: Jun 29, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
Developing and validating a nomogram for penile cancer survival: A comprehensive study based on SEER and Chinese data
Jiawen Luo1,2, Jintao Hu1,2, Yelisudan Mulati1,2
1Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Cancer Medicine
|April 3, 2024
Summary
This study developed a penile cancer nomogram using SEER and Chinese data, outperforming TNM staging for predicting overall survival (OS) and improving clinical decisions.
Area of Science:
- Oncology
- Medical Statistics
- Cancer Research
Background:
- Penile cancer research and clinical guidelines are limited.
- Accurate prognostic tools are crucial for patient management.
Purpose of the Study:
- To develop and validate a nomogram for predicting overall survival (OS) in penile cancer patients.
- To compare the nomogram's efficacy against the TNM staging system.
Main Methods:
- Utilized data from 5744 penile cancer patients (2004-2019) from the Surveillance, Epidemiology, and End Results (SEER) database and 103 patients from a Chinese institution.
- Constructed and validated a nomogram using regression analysis, concordance index (c-index), and decision curve analysis.
- Compared nomogram performance with the TNM staging model.
Main Results:
- Identified nine independent risk factors: age, race, marital status, tumor grade, histology, TNM stage, and surgical approach.
- The nomogram demonstrated strong predictive accuracy (c-index > 0.73) and clinical relevance in internal and external validation cohorts.
- The nomogram significantly outperformed the TNM staging system in predictive efficiency.
Conclusions:
- This study presents the first nomogram for penile cancer prognosis validated with SEER data and institutional records.
- The developed nomogram serves as a superior tool for predicting penile cancer prognosis compared to TNM staging.
- Findings enhance clinical decision-making for surgeons managing penile cancer patients.
Related Concept Videos
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181

